Pertussis Toxin (PT)
[Edit]Pertussis toxin (PT) is a protein-based AB5-type exotoxin produced by the bacterium Bordetella pertussis, which causes whooping cough. PT is involved in the colonization of the respiratory tract and the establishment of infection. Research suggests PT may have a therapeutic role in treating a number of common human ailments, including hypertension, viral inhibition, and autoimmune inhibition. PT is released from B. pertussis in an inactive form. Following PT binding to a cell membrane receptor, it is taken up in an endosome, after which it undergoes retrograde transport to the trans-Golgi network and endoplasmic reticulum. At some point during this transport, the A subunit (or protomer) becomes activated, perhaps through the action of glutathione and ATP. PT catalyzes the ADP-ribosylation of the αi subunits of the heterotrimeric G protein.
Organism species: Pan-species (General)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Complete Antigen of Pertussis Toxin (PT) | Antigenic Transformation Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Pertussis Toxin (PT) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Pertussis Toxin (PT) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Pertussis Toxin (PT) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Pertussis Toxin (PT) | ELISA Kit Customized Service Offer |